Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on September 3, 2026

2 hours ago

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire

5 hours ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire

5 hours ago

Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS

Indeterminate GlobeNewswire

17 hours ago

As AI reshapes business, Newsmatics teams up with Masaryk University to let students tackle real-world challenges

Indeterminate EIN Presswire

5 hours ago

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

Indeterminate GlobeNewswire

5 hours ago

DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre

Indeterminate GlobeNewswire

5 hours ago

DBV Technologies to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

5 hours ago

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Indeterminate GlobeNewswire

5 hours ago

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

New U.S. Treatment Recommendations Published for Severe Alopecia Areata in Adults

Indeterminate GlobeNewswire

6 hours ago

Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

6 hours ago

Vivani Medical Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism

Indeterminate GlobeNewswire

6 hours ago

L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.

Indeterminate GlobeNewswire

6 hours ago

LB Pharmaceuticals to Participate in Upcoming September Investor Events

Indeterminate GlobeNewswire

6 hours ago

Agomab to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

CapsoVision to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Immuneering to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

6 hours ago

Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire